Employee growth to continue as Genmab offices specialize across the globe

Global staffing at Danish biotech company Genmab has soared in recent years, and Genmab’s CEO Jan van de Winkel says the key to the division of labor is smart hiring across the world.

Jan van de Winkel, CEO of Genmab | Photo: Stine Bidstrup/ERH

Any doubts about Danish biotech firm Genmab’s continued growth can be dispelled by looking at the company’s progression in employee numbers in recent years.

Back in 2017, there were 235 people employed at Genmab. The year after, that number was 313, in 2019 it grew to 471, and in 2020, Genmab had 656 employees. In the company’s recently publicized report for 2021, Genmab’s staff counted 1,022 persons.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs